Publications by authors named "Angels Arcusa"

Claim this Profile
L
Laboratory Cross-Comparison and Ring Test Trial for Tumor Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, Gorka Alkorta-Aranburu, Jose Ramon Antunez-Lopez, Angels Arcusa

J Pers Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
Nerea Fernández de Larrea-Baz, Beatriz Pérez-Gómez, Ángel Guerrero-Zotano, Ana María Casas, Begoña Bermejo, Angels Arcusa

Sci Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.
Ignacio Romero, Pedro Mallol, Ana Santaballa, Jose M Del Campo, Marta Mori, Ángels Arcusa

Anticancer Drugs· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Noemí Cerulla, Àngels Arcusa, José-Blas Navarro, Nuria de la Osa, Maite Garolera

J Clin Exp Neuropsychol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study.
Virginia Lope, Miguel Martín, Adela Castelló, Amparo Ruiz, Ana Mª Casas, Angels Arcusa

Sci Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Noemie Travier, Genevieve Buckland, Joan J Vendrell, Sonia Fernandez-Veledo, Immaculada Peiró, Angels Arcusa

Eur J Cancer Care (Engl)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study.
Noemí Cerulla, Àngels Arcusa, José-Blas Navarro, Maite Garolera, Cristina Enero

Breast Cancer Res Treat· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse.
Aleix Prat, Ana Lluch, Arran K Turnbull, Anita K Dunbier, Lourdes Calvo, Angels Arcusa

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer.
Miguel Martín, Milagros González-Rivera, Serafín Morales, Juan de la Haba-Rodriguez, Lucía González-Cortijo, Angels Arcusa

Curr Med Res Opin· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are breast cancer patients treated with radiotherapy younger now than ten years ago?
Marta Bonet, Pere Godoy, Maria Jose Cambra, Encarna Mur, Manel Algara, Àngels Arcusa

Rep Pract Oncol Radiother· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution melting analysis of the common c.1905+1G>A mutation causing dihydropyrimidine dehydrogenase deficiency and lethal 5-fluorouracil toxicity.
Emma Borràs, Emma Dotor, Angels Arcusa, Maria J Gamundi, Imma Hernan

Front Genet· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status.
Francese Casas, Concha León, Esther Jovell, Joana Gómez, Angelo Corvitto, Angels Arcusa

Clin Transl Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
Emma Borràs, Ismael Jurado, Imma Hernan, María José Gamundi, Miguel Dias, Angels Arcusa

BMC Cancer· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant docetaxel for high-risk, node-negative breast cancer.
Miguel Martín, Miguel A Seguí, Antonio Antón, Amparo Ruiz, Manuel Ramos, Angels Arcusa

N Engl J Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family.
Orland Diez, Sara Gutiérrez-Enríquez, Miriam Masas, Anna Tenés, Carme Yagüe, Angels Arcusa

Breast Cancer Res Treat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status.
Luis A Fernández-Morales, Miquel A Seguí, Xavier Andreu, Elsa Dalmau, Amparo Sáez, Angels Arcusa

Clin Breast Cancer· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
Francisco Rodríguez-Moranta, Joan Saló, Angels Arcusa, Jaume Boadas, Virgínia Piñol

J Clin Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial.
Amadeu Pelegrí, Lourdes Calvo, Antonio Antón, José I Mayordomo, Jesus Florián, Angels Arcusa

Clin Breast Cancer· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
Miquel Nogué, Antonieta Salud, Eduard Batiste-Alentorn, Eugeni Saigí, Ferran Losa, Angels Arcusa

Eur J Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial.
Amadeu Pelegrí, Lourdes Calvo, José I Mayordomo, Jesús Florián, Santiago Vázquez, Angels Arcusa

Semin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer.
Miquel Nogué, Lluis Cirera, Angels Arcusa, Eduard Batiste-Alentorn, Anna Balil

Anticancer Drugs· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis